Hydroxyurea with Radiation Therapy of the Carcinoma of the Cervix IIA, IIB.
- Author:
Jin Hee KIM
1
;
Seon Min YOUN
;
Ok Bae KIM
Author Information
1. Department of Radiation Oncology, Keimyung University School of Medicine, Taegu, Korea.
- Publication Type:Original Article
- Keywords:
Hydroxyurea;
Carcinma of the cervix;
Radiation therapy
- MeSH:
Anemia;
Cervix Uteri*;
Female;
Follow-Up Studies;
Humans;
Hydroxyurea*;
Radiation Oncology;
Recurrence;
Survival Rate;
Thrombocytopenia
- From:Journal of the Korean Society for Therapeutic Radiology
1995;13(4):369-376
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the efficacy of hydroxyurea with radiation in carcinoma of the cervix, huge exophytic or endophytic stage IIa and Iib. MATERIALS AND METHODS: Sixty four patients with carcinoma of the cervix stage IIA(29 patients) with exophytic(> or =3cm in diameter) or huge endophytic mass and IIB(35 patients) treated with radiation and hydroxyurea at the Department of Radiation Oncology, Dongsan Hospital, Keimyung University, School of Medicine from Aug, 1989 to May, 1991. The maximum and mean follow up durations were 68 and 57 months respectively. The radiation therapy consisted of external irradiation to the whole pelvis(3600-5400cGy) shield (4X10 cm), and combined with intracavitary irradiation (3000-3500cGy to point A). Hydroxyurea was to be taken in a single oral dose of 1.0gm/day during radiation therapy. RESULTS: The control rate was 89.1%. The actuarial overall five year survival rate was 78.8% for stage IIA and 72.8% for stage IIB. The overall recurrence rate was 25%(16/64). Twenty-three percent of the patients developed or greater thrombocytopenia. Grade 3 or greater GI, GU complication and anemia were not noted. There was no treatment related death noted. CONCLUSION: We considered that hydroxyurea and radiation therapy may improve survival rate in huge exophytic and endophytic stage IIa cervical carcinoma with acceptible morbidity.
